SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-037068
Filing Date
2023-10-12
Accepted
2023-10-12 17:10:17
Documents
18
Period of Report
2023-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 69813
2 AMENDED AND RESTATED CONTRIBUTION AGREEMENT ex10-1.htm EX-10.1 192312
3 SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY OPERATING AGREEMENT ex10-2.htm EX-10.2 307123
4 OCEAN BIOMEDICAL AND VIRION THERAPEUTICS FORM JOINT VENTURE SUPPORTING MULTI-NAT ex99-1.htm EX-99.1 23594
5 ex99-1_001.jpg GRAPHIC 2064
6 ex99-1_002.jpg GRAPHIC 2690
  Complete submission text file 0001493152-23-037068.txt   929992

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ocea-20231006.xsd EX-101.SCH 3865
8 XBRL DEFINITION FILE ocea-20231006_def.xml EX-101.DEF 27188
9 XBRL LABEL FILE ocea-20231006_lab.xml EX-101.LAB 37603
10 XBRL PRESENTATION FILE ocea-20231006_pre.xml EX-101.PRE 25809
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5698
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 231323357
SIC: 2834 Pharmaceutical Preparations